Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Federica Favales"'
Autor:
Loris De Cecco, Marco Giannoccaro, Edoardo Marchesi, Paolo Bossi, Federica Favales, Laura D. Locati, Lisa Licitra, Silvana Pilotti, Silvana Canevari
Publikováno v:
Genes, Vol 8, Iss 1, p 35 (2017)
This paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomark
Externí odkaz:
https://doaj.org/article/0bf15f5b99204a44b38c601d00c03486
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Fig S2. Technical validation using NuGEN's Ovation System. The scatter plot shows the fold change consistency of genes differentially expressed using WG-DASL and NuGEN methods. Only 6 out of the 509 DE genes were found discordant, confirming the WG-D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07c1521837d8735544ec5a5971a5bdf
https://doi.org/10.1158/1078-0432.22455138
https://doi.org/10.1158/1078-0432.22455138
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Fig S1. Volcano plot for the 17,378 genes detected by microarray analysis. The x-axis is the fold-change, and the y-axis is log10 p value. A total of 509 probes (blue dots) were differentially expressed in long-PFS patients (14) compared with short-P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bbd01208fe38f28ae4e75cc51e8d56
https://doi.org/10.1158/1078-0432.22455141.v1
https://doi.org/10.1158/1078-0432.22455141.v1
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
FigS3: Biasogram representing the influence of tissue origin on outcome. Y axes indicate the outcome vector (long- versus short- PFS), while B indicates the nuisance variable (tissue origin; primary versus recurrence/metastatic). The colorgram repres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77bab4e61f992b12e2f8b497435ca156
https://doi.org/10.1158/1078-0432.22455135
https://doi.org/10.1158/1078-0432.22455135
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Purpose: To identify the tumor portrait of the minority of head and neck squamous cell carcinoma (HNSCC) patients with recurrent–metastatic (RM) disease who upon treatment with platinum-based chemotherapy plus cetuximab present a long-lasting respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da047f43ec3b38607fca1827ca3599e
https://doi.org/10.1158/1078-0432.c.6522930.v1
https://doi.org/10.1158/1078-0432.c.6522930.v1
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Fig S4. Ability of existing gene signatures to predict outcome following cetuximab treatment. Five available prognostic gene-expression based signatures were taken into account: i) the hypoxia metagene (Winter, 2007); ii) the 13-gene OSCC signature (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9466d780ea76bd52e357fe1e0dec8065
https://doi.org/10.1158/1078-0432.22455132.v1
https://doi.org/10.1158/1078-0432.22455132.v1
Autor:
Loris De Cecco, Silvana Canevari, Lisa Licitra, Laura D. Locati, Silvana Pilotti, Federica Perrone, Barbara Cortelazzi, Edoardo Marchesi, Marco Giannoccaro, Federica Favales, Andrea P. Sponghini, Maria Cossu Rocca, Marco Siano, Cristiana Bergamini, Paolo Bossi
Supplementary Table S2 Gene sets associated to long- and short-PFS patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::770eb1544e2b03b9c486e9773baa52cd
https://doi.org/10.1158/1078-0432.22455126.v1
https://doi.org/10.1158/1078-0432.22455126.v1
Autor:
Federica Favales, A. Cavallo, Salvatore Alfieri, F. Bonfantini, Ester Orlandi, Nicola Alessandro Iacovelli, Carlo Fallai, Cristiana Bergamini, Emanuele Pignoli, Paolo Bossi, Simona Naimo
Publikováno v:
Supportive Care in Cancer. 25:1787-1795
The purpose of this study was to investigate efficacy, safety and tolerability of Xonrid®, a new medical device, in preventing radiation dermatitis associated with head and neck cancer (HNC) radiotherapy (RT). In this monocentric, prospective pilot
Autor:
Barbara Cortelazzi, Laura D. Locati, Silvana Canevari, Marco Giannoccaro, Andrea Pietro Sponghini, Federica Perrone, Cristiana Bergamini, Edoardo Marchesi, M. Siano, Federica Favales, Maria Cossu Rocca, Lisa Licitra, Silvana Pilotti, Paolo Bossi, Loris De Cecco
Publikováno v:
Clinical Cancer Research. 22:3961-3970
Purpose: To identify the tumor portrait of the minority of head and neck squamous cell carcinoma (HNSCC) patients with recurrent–metastatic (RM) disease who upon treatment with platinum-based chemotherapy plus cetuximab present a long-lasting respo
Autor:
Laura D. Locati, Lisa Licitra, Cristiana Bergamini, Augusto Genderini, Stefano Cavalieri, Federica Favales, Manuela Nebuloni, Salvatore Alfieri, Paola Pistillo, Antonella Tosoni, Paolo Bossi, Laura Cosmai
INTRODUCTION Lenvatinib (LEN) is a multi-kinase anti-angiogenic drug recently approved in several cancers. LEN is not easily manageable due to its complex safety profile. Proteinuria and renal failure (RF) were reported among the most frequent LEN-in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1502f56e9d6fc13f7567bc775f1fbe64
http://hdl.handle.net/11379/533758
http://hdl.handle.net/11379/533758